Clinical Trials Logo

Filter by:
NCT ID: NCT01303614 Not yet recruiting - Clinical trials for Gynecological Pathology

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice

HSG-2010
Start date: April 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysterosalpingography diagnostic practice.

NCT ID: NCT01282398 Not yet recruiting - Liver Cirrhosis Clinical Trials

Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis

SIMPRO
Start date: April 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether simvastatin is effective in the prevention of progression of porta hypertension in compensated cirrhosis patients.

NCT ID: NCT01282385 Not yet recruiting - Liver Cirrhosis Clinical Trials

Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension

SIMBETA
Start date: April 2011
Phase: Phase 4
Study type: Interventional

In the genesis and maintenance of PH associated with liver cirrhosis are two mechanisms that act synergistically. The first is an increase in hepatic vascular resistance, due in part to the disruption of liver structure inherent cirrhosis, and increased hepatic vascular tone is caused by the contraction of perivascular smooth muscle cells, myofibroblasts and hepatic stellate cells, which represents about 30% of global intrahepatic resistance and is believed to be due to the production Defective nitric oxide (NO). The second mechanism, which maintains and exacerbates HTP, is an increase of splanchnic blood flow caused by increased NO and other vasodilators at this level In this regard, we believe that in patients with compensated liver cirrhosis, with portal pressure gradient> 10 mmHg, both acute responders betablockers test as non-responders, the association of antifibrotic drugs and / or vasodilators, chronic liver selective May be beneficial in the control of portal hypertension

NCT ID: NCT01277627 Not yet recruiting - HCV Viral Load. Clinical Trials

Influence of Nevirapine on HCV Viral Load

HELICON
Start date: January 2011
Phase: N/A
Study type: Interventional

Nevirapine-based antiretroviral therapy is associated with lower plasma HCV viral load in HIV/HCV-coinfected individuals.

NCT ID: NCT01264978 Not yet recruiting - COPD Clinical Trials

Evaluation of Utility Quadriceps Magnetic Stimulation in COPD (Chronic Obstructive Pulmonary Disease) Patients After Hospital Exacerbation

COPD
Start date: January 2011
Phase: Phase 3
Study type: Interventional

The aims of this study are:1.To evaluate the utility of quadriceps RMNMS (repetitive magnetic neuromuscular stimulation) in the evolution of COPD patients after hospital admission for acute exacerbation.2 To evaluate the time schedule of recovery changes in muscle parameters ,exercise capacity and quality of life after acute exacerbation. 3.To test the use of this new method of training in acute clinical situations. Patients: COPD patients admitted to the Hospital with acute exacerbation. Group 1: RMNMS Treatment .Group 2 : sham RMNMS treatment. Randomized assignment by minimization method. PROTOCOL Training Group: 10 days after discharge and during 8 weeks, 2-3 days/week. Measures: Spirometry, Plethysmography ,Diffusion Test. Main outcomes: Exercise test (Six minutes walking distance). Muscle function: MVC. Health related quality of life.

NCT ID: NCT01235013 Not yet recruiting - HIV-1 Infection Clinical Trials

Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3

DIS-MVC
Start date: n/a
Phase: Phase 4
Study type: Interventional

Maraviroc is an antiretroviral drug that belongs to the family of the CCR5 coreceptor inhibitors. It has proven to be effective in increasing CD4 lymphocyte counts in both in treated and naïve patients, irrespective of the viral load. The investigators hypothesize that adding Maraviroc to the antiretroviral treatment of discordant patients, defined as those having CD4 lymphocyte counts below 200 cells /mm3 during the last year, could lead to its immunological recovery. 60 patients will be included in this unicentric, prospective, randomized and stratified clinical trial. They will be randomized to either continue with its usual high activity antiretroviral therapy (HAART) treatment or to receive 300 mg of Maraviroc every 12 hours plus its usual treatment. After 24 weeks, lymphocyte counts will be assessed, as well as safety, clinical progression, immunological profile of the patients and the potential benefit of Maraviroc for HIV+ cirrhotic patients.

NCT ID: NCT01212640 Not yet recruiting - Acute Lung Injury Clinical Trials

GROUP FOR TRALI STUDY. SEMICYUC.

Start date: October 2010
Phase: N/A
Study type: Observational

OBJETIVES: 1. To research the worsening of respiratory status risk factors after transfusion in spanish critical care units. 2. To determine the incidence of transfusion-related acute lung injury (TRALI) in critically ill patients. 3. To research the morbi-mortality of TRALI.

NCT ID: NCT01088282 Not yet recruiting - Presbyopia Clinical Trials

Visual and Economic Profits of ReSTOR® Multifocal Intraocular Lenses (IOL) on Public Health Patients in Spain

Start date: March 2010
Phase: N/A
Study type: Interventional

Surgical correction of presbyopia is possible via the implantation of multifocal intraocular lenses after removal of the crystalline lens. The cost of these implants is approximately 6 times higher than the conventional monofocal implants routinely used in all crystalline surgery for correction of the resulting ametropia. Spectacles for correcting presbyopia, which are necessary after the insertion of monofocal implants, may also have a significant cost. The proposed trial will involve two randomized groups of patients in need of crystalline/cataract surgery, with monofocal or multifocal lens implants (the same type of lens in both eyes) leaving them emmetropic for distant vision. The objective is to corroborate with blind-evaluation the effectiveness of multifocal lens implants in obviating the need for glasses to correct presbyopia, to evaluate the benefits of this type of implant, both in global economic terms (adding the cost of the implants to that of corrective glasses where necessary) and in terms of the improved quality of life of the patients, and to confirm the absence of adverse effects. Findings will be subjected to a statistical quantification.

NCT ID: NCT01084122 Not yet recruiting - Hip Fracture Clinical Trials

Efficacy and Safety of Intravenous Iron Sucrose in Patients With Hip Fracture to Prevent Perioperative Anemia

Start date: May 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of intravenous iron sucrose in patients with hip fracture and surgical intervention to prevent perioperative anemia.

NCT ID: NCT01014325 Not yet recruiting - Allergic Rhinitis Clinical Trials

Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy

Start date: September 2016
Phase: Phase 3
Study type: Interventional

The objective of this clinical trial is to assess the safety and efficacy of sublingual application of allergen extracts for specific immunotherapy in patients suffering from perennial allergic rhinitis due to house dust mites.